tradingkey.logo
tradingkey.logo
Search

Compass Therapeutics Inc.

CMPX
Add to Watchlist
1.900USD
+0.050+2.70%
Close 09-18 16:00ET
341.27MMarket Cap
LossP/E TTM
After-hours 19:11 (ET)1.875USD-0.010-0.53%

CMPX Financials

See Compass Therapeutics Inc.'s financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
341.27M
Dividend TTM
0.00
P/E TTM
-4.74
EPS TTM
-0.40
Revenue
0.00
Net Profit
-49.38M
ROE
-45.95%
ROA
-40.50%

Compass Therapeutics Inc. Earnings Date

Latest Release
Aug 6, 2026
EPS / Forecast
-0.13/-0.11
Revenue / Forecast
--/0.00

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
6.34%-0.13
18.33%-0.10
22.22%-0.08
-10.90%-0.08
-51.27%-0.14
-52.38%-0.12
-3.79%-0.11
2.58%-0.08
-6.80%-0.10
-27.33%-0.08
-6.94%-0.11
---0.08
---0.09
---0.06
---0.10
----
----
----
----
----
Revenue
----
----
--0.00
--0.00
-100.00%0.00
----
--0.00
--0.00
--850.00K
----
----
----
----
----
----
----
----
----
----
----
Net Profit
-26.52%-25.15M
-10.12%-18.32M
-4.54%-15.72M
-36.05%-14.26M
-52.04%-19.88M
-54.19%-16.63M
-12.06%-15.03M
-5.19%-10.48M
-15.94%-13.08M
-37.64%-10.79M
-15.71%-13.41M
16.79%-9.96M
-32.78%-11.28M
-9.42%-7.84M
10.68%-11.59M
-100.42%-11.97M
84.78%-8.49M
3.50%-7.16M
-54.70%-12.98M
34.70%-5.97M
Net Margin
----
----
----
----
----
----
----
----
---1538.35%
----
----
----
----
----
----
----
----
----
----
----
Gross Margin
----
----
----
----
----
----
----
----
--100.00%
----
----
----
----
----
----
----
----
----
----
----
Revenue
----
----
--0.00
--0.00
-100.00%0.00
----
--0.00
--0.00
--850.00K
----
----
----
----
----
----
----
----
----
----
----
Operating profit
-28.07%-26.98M
-12.99%-20.30M
-8.54%-17.99M
-29.23%-15.82M
-40.02%-21.07M
-40.69%-17.97M
-7.67%-16.57M
-2.62%-12.24M
-12.81%-15.04M
-31.50%-12.77M
-19.44%-15.39M
5.33%-11.93M
-48.40%-13.34M
-35.21%-9.71M
0.87%-12.89M
-115.20%-12.60M
-77.22%-8.99M
2.14%-7.18M
-63.53%-13.00M
34.67%-5.85M
Net Profit
-26.52%-25.15M
-10.12%-18.32M
-4.54%-15.72M
-36.05%-14.26M
-52.04%-19.88M
-54.19%-16.63M
-12.06%-15.03M
-5.19%-10.48M
-15.94%-13.08M
-37.64%-10.79M
-15.71%-13.41M
16.79%-9.96M
-32.78%-11.28M
-9.42%-7.84M
10.68%-11.59M
-100.42%-11.97M
84.78%-8.49M
3.50%-7.16M
-54.70%-12.98M
34.70%-5.97M
Current assets
70.34%180.89M
57.63%195.69M
58.05%209.82M
56.67%221.12M
-30.84%106.19M
-21.73%124.14M
-13.73%132.75M
-15.27%141.14M
-12.40%153.55M
-13.61%158.61M
-21.00%153.88M
35.93%166.58M
30.27%175.27M
30.88%183.60M
32.42%194.79M
328.93%122.55M
289.60%134.54M
236.84%140.28M
193.03%147.10M
-50.59%28.57M
Total current liabilities
16.38%16.13M
-31.01%10.28M
57.40%13.97M
179.99%12.41M
45.77%13.86M
282.74%14.90M
13.75%8.87M
-51.41%4.43M
-1.97%9.51M
-65.21%3.89M
-51.75%7.80M
-4.74%9.12M
-10.90%9.70M
19.88%11.19M
52.09%16.17M
24.66%9.58M
29.68%10.88M
-13.97%9.33M
5.27%10.63M
-20.57%7.68M
Total assets
62.96%190.17M
56.08%205.17M
56.40%219.59M
55.05%231.26M
-25.01%116.70M
-18.43%131.45M
-10.50%140.40M
-12.28%149.15M
-13.15%155.61M
-14.27%161.14M
-21.42%156.88M
33.01%170.04M
27.75%179.18M
28.25%187.97M
29.84%199.65M
266.31%127.84M
243.16%140.26M
204.09%146.56M
196.19%153.76M
-42.50%34.90M
Total liabilities
2.69%24.12M
-11.69%18.70M
50.28%22.80M
101.30%21.65M
147.09%23.49M
418.67%21.17M
81.96%15.17M
7.61%10.75M
-12.74%9.51M
-67.88%4.08M
-53.70%8.34M
-14.75%9.99M
-18.25%10.89M
5.27%12.71M
31.64%18.01M
6.46%11.72M
11.09%13.33M
-18.01%12.07M
14.32%13.68M
-17.85%11.01M
Total equity
78.15%166.05M
69.09%186.47M
57.14%196.79M
51.46%209.61M
-36.21%93.21M
-29.79%110.28M
-15.69%125.23M
-13.53%138.40M
-13.18%146.10M
-10.39%157.06M
-18.22%148.54M
37.83%160.04M
32.58%168.29M
30.32%175.26M
29.67%181.64M
386.09%116.12M
339.58%126.93M
301.81%134.49M
250.68%140.08M
-49.48%23.89M
Net operating income
-24.56%-14.74M
-30.75%-17.27M
-44.66%-13.25M
1.83%-10.85M
-10.02%-11.83M
4.90%-13.21M
25.84%-9.16M
-86.61%-11.05M
-6.34%-10.75M
-13.57%-13.89M
-16.10%-12.35M
45.88%-5.92M
-119.85%-10.11M
-53.98%-12.23M
-128.10%-10.64M
-216.52%-10.94M
22.55%-4.60M
-41.69%-7.94M
29.03%-4.67M
51.78%-3.46M
Net investment
21.75%-4.98M
231.63%38.43M
-121.98%-3.38M
-427.92%-95.16M
-198.10%-6.36M
382.70%11.59M
143.43%15.37M
70.20%29.02M
1071.96%6.48M
-196.02%-4.10M
113.54%6.31M
1344.83%17.05M
99.37%-667.00K
2311.92%4.27M
-5911.08%-46.65M
421.53%1.18M
-17089.09%-105.54M
-1384.62%-193.00K
-13033.33%-776.00K
-5142.86%-367.00K
Net financing
--0.00
512.88%3.37M
1230.85%1.06M
6468150.00%129.36M
-100.00%0.00
-104.68%-815.00K
40.51%-94.00K
-109.52%-2.00K
-99.97%1.00K
42419.51%17.43M
-100.21%-158.00K
320.00%21.00K
--3.03M
--41.00K
-39.03%75.75M
100.27%5.00K
100.00%0.00
100.00%0.00
6725.92%124.24M
29.96%-1.88M

Revenue

By Business

Period:
No Data

By Region

Period:
No Data

FAQs

What are the current assets of Compass Therapeutics Inc.?

According to Compass Therapeutics Inc.'s FY2025 earnings report, its current assets were 209.82M, with a year-on-year change of 58.05.

What are the total assets of Compass Therapeutics Inc.?

According to Compass Therapeutics Inc.'s FY2025 earnings report, its total assets of Compass Therapeutics Inc. were 219.59M, with a year-on-year change of 56.40.

What are the total liabilities of Compass Therapeutics Inc.?

According to Compass Therapeutics Inc.'s FY2025 earnings report, its total liabilities of Compass Therapeutics Inc. were 22.80M, with a year-on-year change of 50.28.

What is the total equity of Compass Therapeutics Inc.?

According to Compass Therapeutics Inc.'s FY2025 earnings report, its total equity of Compass Therapeutics Inc. was 196.79M, with a year-on-year change of 57.14.

What is the net operating income of Compass Therapeutics Inc.?

According to Compass Therapeutics Inc.'s FY2025 earnings report, its net operating income of Compass Therapeutics Inc. was -72.84M, with a year-on-year change of -28.63.

What is the net investment of Compass Therapeutics Inc.?

According to Compass Therapeutics Inc.'s FY2025 earnings report, its net investment of Compass Therapeutics Inc. was -93.31M, with a year-on-year change of -299.49.

What is the net financing of Compass Therapeutics Inc.?

According to Compass Therapeutics Inc.'s FY2025 earnings report, its net financing of Compass Therapeutics Inc. was 129.61M, with a year-on-year change of 647.54.

What is the Earnings Per Share (EPS) of Compass Therapeutics Inc.?

According to Compass Therapeutics Inc.'s FY2025 earnings report, its Earnings Per Share (EPS) was -0.42, with a year-on-year change of -17.32.

What is the net income of Compass Therapeutics Inc.?

According to Compass Therapeutics Inc.'s FY2025 earnings report, its net income was -66.49M, with a year-on-year change of -34.66.

What is the Return on Equity (ROE) of Compass Therapeutics Inc.?

According to Compass Therapeutics Inc.'s FY2025 earnings report, its Return on Equity (ROE) was -41.29, with a year-on-year change of -14.48.

What is the Return on Assets (ROA) of Compass Therapeutics Inc.?

According to Compass Therapeutics Inc.'s FY2025 earnings report, its Return on Assets (ROA) was -36.94, with a year-on-year change of -11.20.

What is the operating profit of Compass Therapeutics Inc.?

According to Compass Therapeutics Inc.'s FY2025 earnings report, its operating profit was -72.84M, with a year-on-year change of -28.63.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.